Allergic skin diseases.

The skin is one of the largest immunologic organs and is affected by both external and internal factors, as well as innate and adaptive immune responses. Many skin disorders, such as atopic dermatitis, contact dermatitis, urticaria, angioedema, psoriasis, and autoimmune blistering disorders, are immune mediated. Most of these diseases are chronic, inflammatory, and proliferative, in which both genetic and environmental factors play important roles. These immunologic mechanisms might have implications for potential targets of future therapeutic interventions.

[1]  J. Schroeder,et al.  TLR9- and FcεRI-Mediated Responses Oppose One Another in Plasmacytoid Dendritic Cells by Down-Regulating Receptor Expression1 , 2005, The Journal of Immunology.

[2]  T. Bieber,et al.  Characterization of FcepsilonRI-bearing CD123 blood dendritic cell antigen-2 plasmacytoid dendritic cells in atopic dermatitis. , 2004, The Journal of allergy and clinical immunology.

[3]  D. Melzer,et al.  Filaggrin gene mutations are associated with asthma and eczema in later life. , 2008, The Journal of allergy and clinical immunology.

[4]  C. Akdis,et al.  T helper (Th) 2 predominance in atopic diseases is due to preferential apoptosis of circulating memory/effector Th1 cells , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[5]  E. Warshaw,et al.  North American Contact Dermatitis Group Patch‐Test Results, 2003‐2004 Study Period , 2008, Dermatitis : contact, atopic, occupational, drug.

[6]  E. Mitchell,et al.  A differential effect of 2 probiotics in the prevention of eczema and atopy: a double-blind, randomized, placebo-controlled trial. , 2008, The Journal of allergy and clinical immunology.

[7]  Yongqiang Jiang,et al.  Acute Guttate Psoriasis Patients Have Positive Streptococcus Hemolyticus Throat Cultures and Elevated Antistreptococcal M6 Protein Titers , 2005, The Journal of dermatology.

[8]  H. Wichmann,et al.  Preventive effect of hydrolyzed infant formulas persists until age 6 years: long-term results from the German Infant Nutritional Intervention Study (GINI). , 2008, The Journal of allergy and clinical immunology.

[9]  H. Simon,et al.  Anti-CD20 (rituximab) treatment improves atopic eczema. , 2008, The Journal of allergy and clinical immunology.

[10]  R. Brehler,et al.  Allergic contact dermatitis in children: strategies of prevention and risk management. , 2004, European journal of dermatology : EJD.

[11]  A. Irvine,et al.  Filaggrin in atopic dermatitis. , 2009, The Journal of allergy and clinical immunology.

[12]  T. Bieber,et al.  Interleukin-10 downregulates anti-microbial peptide expression in atopic dermatitis. , 2005, The Journal of investigative dermatology.

[13]  T. Menné,et al.  Systemic contact dermatitis after oral exposure to nickel: a review with a modified meta‐analysis , 2006, Contact dermatitis.

[14]  L. Bielory,et al.  Meta-analysis of clinical trials of probiotics for prevention and treatment of pediatric atopic dermatitis. , 2008, The Journal of allergy and clinical immunology.

[15]  N. Novak,et al.  Network of myeloid and plasmacytoid dendritic cells in atopic dermatitis. , 2007, Advances in experimental medicine and biology.

[16]  M. Flaig,et al.  Cathelicidin deficiency predisposes to eczema herpeticum. , 2006, The Journal of allergy and clinical immunology.

[17]  T. Illig,et al.  Toward a major risk factor for atopic eczema: meta-analysis of filaggrin polymorphism data. , 2007, The Journal of allergy and clinical immunology.

[18]  J. Carucci,et al.  Major differences in inflammatory dendritic cells and their products distinguish atopic dermatitis from psoriasis. , 2007, The Journal of allergy and clinical immunology.

[19]  P. Elias,et al.  Basis for the barrier abnormality in atopic dermatitis: outside-inside-outside pathogenic mechanisms. , 2008, The Journal of allergy and clinical immunology.

[20]  Jeanne D Johansen,et al.  Fragrance Contact Allergy , 2003, American journal of clinical dermatology.

[21]  S. Seidenari,et al.  Patch testing with corticosteroid mixes in Europe , 2000, Contact dermatitis.

[22]  E. Knol,et al.  Aberrant function of peripheral blood myeloid and plasmacytoid dendritic cells in atopic dermatitis patients. , 2008, The Journal of allergy and clinical immunology.

[23]  J. Carucci,et al.  Low Expression of the IL-23/Th17 Pathway in Atopic Dermatitis Compared to Psoriasis1 , 2008, The Journal of Immunology.

[24]  E. Warshaw,et al.  Lanolin allergy: history, epidemiology, responsible allergens, and management. , 2008, Dermatitis : contact, atopic, occupational, drug.

[25]  K. Barnes,et al.  Cytokine modulation of atopic dermatitis filaggrin skin expression. , 2007, The Journal of allergy and clinical immunology.

[26]  T. Bieber,et al.  FcepsilonRI engagement of Langerhans cell-like dendritic cells and inflammatory dendritic epidermal cell-like dendritic cells induces chemotactic signals and different T-cell phenotypes in vitro. , 2004, The Journal of allergy and clinical immunology.

[27]  C. Bindslev‐Jensen,et al.  Prevalence of atopic dermatitis, asthma, allergic rhinitis, and hand and contact dermatitis in adolescents. The Odense Adolescence Cohort Study on Atopic Diseases and Dermatitis , 2001, The British journal of dermatology.

[28]  A. Cristaudo,et al.  Contact sensitivity to hair dyes can be detected by the consumer open test. , 2002, European journal of dermatology : EJD.

[29]  I. Duarte,et al.  Hand eczema: evaluation of 250 patients. , 1998, American journal of contact dermatitis : official journal of the American Contact Dermatitis Society.

[30]  D. Khan,et al.  Therapeutic alternatives for chronic urticaria: an evidence-based review, Part 2. , 2008, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[31]  T. Chatila,et al.  Allergic dysregulation and hyperimmunoglobulinemia E in Foxp3 mutant mice. , 2005, The Journal of allergy and clinical immunology.

[32]  C. Grattan,et al.  Guidelines for evaluation and management of urticaria in adults and children , 2007, The British journal of dermatology.

[33]  A. Kaplan,et al.  Chronic urticaria: what is new, where are we headed. , 2007, Allergologia et immunopathologia.

[34]  E. Warshaw,et al.  Parabens: a review of epidemiology, structure, allergenicity, and hormonal properties. , 2005, Dermatitis : contact, atopic, occupational, drug.

[35]  J. Lepoittevin,et al.  Studies in patients with corticosteroid contact allergy. Understanding cross-reactivity among different steroids. , 1995, Archives of dermatology.

[36]  T. Wienker,et al.  A major susceptibility locus for atopic dermatitis maps to chromosome 3q21 , 2000, Nature Genetics.

[37]  A. Dirksen,et al.  Allergic contact sensitization in an adult Danish population: two cross-sectional surveys eight years apart (the Copenhagen Allergy Study). , 2001, Acta dermato-venereologica.

[38]  D. Strachan,et al.  Reduced diversity in the early fecal microbiota of infants with atopic eczema. , 2008, The Journal of allergy and clinical immunology.

[39]  G. Hartmann,et al.  Plasmacytoid dendritic cells: a new cutaneous dendritic cell subset with distinct role in inflammatory skin diseases. , 2002, The Journal of investigative dermatology.

[40]  B. Mazur,et al.  Staphylococcus aureus skin colonization in atopic dermatitis children is associated with decreased IFN‐γ production by peripheral blood CD4+ and CD8+ T cells , 2007, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

[41]  H. Maibach,et al.  Gold allergy in North America. , 2001, American journal of contact dermatitis : official journal of the American Contact Dermatitis Society.

[42]  Kathleen M. Smith,et al.  Human epithelial cells trigger dendritic cell–mediated allergic inflammation by producing TSLP , 2002, Nature Immunology.

[43]  A. Ehrlich,et al.  Allergic contact dermatitis to gold. , 2000, Cutis.

[44]  C. Strobl,et al.  Analysis of the individual and aggregate genetic contributions of previously identified serine peptidase inhibitor Kazal type 5 (SPINK5), kallikrein-related peptidase 7 (KLK7), and filaggrin (FLG) polymorphisms to eczema risk. , 2008, The Journal of allergy and clinical immunology.

[45]  J. Guin Eyelid dermatitis: experience in 203 cases. , 2002, Journal of the American Academy of Dermatology.

[46]  Antonio Prado Moreno,et al.  Vlerick Leuven Gent Working Paper Series 2003/22 Starting Resource Configurations of Research-based Start-ups and the Interaction with Technology , 2022 .

[47]  I. Duarte,et al.  Contact dermatitis of the feet: a study of 53 cases. , 2004, Dermatitis : contact, atopic, occupational, drug.

[48]  S. Raimer Filaggrin null mutations and childhood atopic eczema: A population-based case-control study , 2009 .

[49]  C. Sitaru,et al.  Immunopathology and molecular diagnosis of autoimmune bullous diseases , 2007, Journal of cellular and molecular medicine.

[50]  Lisa C. Zaba,et al.  IL-22-producing "T22" T cells account for upregulated IL-22 in atopic dermatitis despite reduced IL-17-producing TH17 T cells. , 2009, The Journal of allergy and clinical immunology.

[51]  Erin G Harper,et al.  Pathophysiology of psoriasis: Recent advances on IL-23 and Th17 cytokines , 2007, Current rheumatology reports.

[52]  C. W. Carspecken,et al.  Defective killing of Staphylococcus aureus in atopic dermatitis is associated with reduced mobilization of human beta-defensin-3. , 2008, The Journal of allergy and clinical immunology.

[53]  S. Weiland,et al.  Filaggrin mutations, atopic eczema, hay fever, and asthma in children. , 2008, The Journal of allergy and clinical immunology.

[54]  D. Khan,et al.  Therapeutic alternatives for chronic urticaria: an evidence-based review, part 1. , 2008, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[55]  L. Vaillant,et al.  A comparison of oral and topical corticosteroids in patients with bullous pemphigoid. , 2002, The New England journal of medicine.

[56]  G. Stingl,et al.  Atopic dermatitis: therapeutic concepts evolving from new pathophysiologic insights. , 2008, The Journal of allergy and clinical immunology.

[57]  K. Heeg,et al.  The Toll-like receptor 2 R753Q mutation modifies cytokine production and Toll-like receptor expression in atopic dermatitis. , 2008, The Journal of allergy and clinical immunology.

[58]  A. Woodcock,et al.  Bifidobacterium pseudocatenulatum is associated with atopic eczema: a nested case-control study investigating the fecal microbiota of infants. , 2008, The Journal of allergy and clinical immunology.

[59]  C. Akdis,et al.  Absence of T-regulatory cell expression and function in atopic dermatitis skin. , 2006, The Journal of allergy and clinical immunology.

[60]  S. M. Wilkinson Corticosteroid cross‐reactions: an alternative view , 2000, Contact dermatitis.

[61]  M. Thompson,et al.  Prevalence and Morphology of Hand Eczema in Patients with Atopic Dermatitis , 2006, Dermatitis : contact, atopic, occupational, drug.

[62]  R. Gallo,et al.  Antimicrobial peptides and the skin immune defense system. , 2008, The Journal of allergy and clinical immunology.

[63]  J. Ring,et al.  IL-17 in atopic eczema: linking allergen-specific adaptive and microbial-triggered innate immune response. , 2009, The Journal of allergy and clinical immunology.

[64]  S. Ziegler,et al.  Spontaneous atopic dermatitis in mice expressing an inducible thymic stromal lymphopoietin transgene specifically in the skin , 2005, The Journal of experimental medicine.

[65]  G. Nakazawa,et al.  The impact of metallic allergy on stent implantation: metal allergy and recurrence of in-stent restenosis. , 2005, International journal of cardiology.

[66]  D. Zillikens,et al.  Mechanisms of blister induction by autoantibodies , 2005, Experimental dermatology.

[67]  M. Pembrey,et al.  The burden of disease associated with filaggrin mutations: a population-based, longitudinal birth cohort study. , 2008, The Journal of allergy and clinical immunology.

[68]  E. Warshaw,et al.  Common Contact Allergens Associated with Eyelid Dermatitis: Data from the North American Contact Dermatitis Group 2003‐2004 Study Period , 2007, Dermatitis : contact, atopic, occupational, drug.

[69]  P. Meroni,et al.  Chronic urticaria: a disease at a crossroad between autoimmunity and coagulation. , 2007, Autoimmunity reviews.

[70]  G. Fabbrocini,et al.  Eyelid dermatitis: an evaluation of 447 patients. , 2003, American journal of contact dermatitis : official journal of the American Contact Dermatitis Society.

[71]  G. Abecasis,et al.  Genetic linkage of childhood atopic dermatitis to psoriasis susceptibility loci , 2001, Nature Genetics.

[72]  G. K. Khurana Hershey,et al.  Intrinsically defective skin barrier function in children with atopic dermatitis correlates with disease severity. , 2008, The Journal of allergy and clinical immunology.

[73]  B. Gesser,et al.  Expression of IL-18 mRNA and secretion of IL-18 are reduced in monocytes from patients with atopic dermatitis. , 2001, The Journal of allergy and clinical immunology.

[74]  I. Bernstein,et al.  Contact dermatitis: a practice parameter , 2006 .

[75]  S. Nasser,et al.  BSACI guidelines for the management of chronic urticaria and angio‐oedema , 2007, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[76]  S. Jacob,et al.  Systemic contact dermatitis. , 2008, Dermatitis : contact, atopic, occupational, drug.

[77]  J. Lannigan,et al.  Analysis of CD25hiCD4+ "regulatory" T-cell subtypes in atopic dermatitis reveals a novel T(H)2-like population. , 2008, The Journal of allergy and clinical immunology.

[78]  L. Beck,et al.  Atopic dermatitis: a disease caused by innate immune defects? , 2009, The Journal of investigative dermatology.

[79]  H. Simon,et al.  Alefacept (lymphocyte function-associated molecule 3/IgG fusion protein) treatment for atopic eczema. , 2008, The Journal of allergy and clinical immunology.

[80]  E. Warshaw,et al.  Hand dermatitis: a review of clinical features, therapeutic options, and long-term outcomes. , 2003, American journal of contact dermatitis : official journal of the American Contact Dermatitis Society.

[81]  Tomas Ganz,et al.  Endogenous antimicrobial peptides and skin infections in atopic dermatitis. , 2002, The New England journal of medicine.

[82]  Thomas Bieber,et al.  Atopic dermatitis. , 2008, The New England journal of medicine.

[83]  G. Imberti,et al.  Eyelid dermatitis: an evaluation of 150 patients , 1992, Contact dermatitis.

[84]  Yong‐jun Liu,et al.  Thymic stromal lymphopoietin converts human epidermal Langerhans cells into antigen-presenting cells that induce proallergic T cells. , 2007, The Journal of allergy and clinical immunology.

[85]  A. Banham,et al.  Regulatory T cells in atopic dermatitis: epidermal dendritic cell clusters may contribute to their local expansion , 2009, The British journal of dermatology.

[86]  James F. Jones,et al.  Cytokine milieu of atopic dermatitis skin subverts the innate immune response to vaccinia virus. , 2006, Immunity.

[87]  A. Bircher,et al.  Baboon syndrome resulting from systemic drugs: is there strife between SDRIFE and allergic contact dermatitis syndrome? , 2004, Contact dermatitis.

[88]  J. Fowler Cocamidopropyl betaine. , 2004, Dermatitis : contact, atopic, occupational, drug.

[89]  Christian W Hamm,et al.  Nickel and molybdenum contact allergies in patients with coronary in-stent restenosis , 2000, The Lancet.

[90]  S. Ständer,et al.  Correlation of IL-31 serum levels with severity of atopic dermatitis. , 2008, The Journal of allergy and clinical immunology.

[91]  J. Schroeder,et al.  Human blood dendritic cells from allergic subjects have impaired capacity to produce interferon‐α via toll‐like receptor 9 , 2008, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[92]  S. Saini,et al.  New concepts in chronic urticaria. , 2008, Current opinion in immunology.

[93]  R. Gallo,et al.  Administration of oral vitamin D induces cathelicidin production in atopic individuals. , 2008, The Journal of allergy and clinical immunology.